Search

Author/Creator Krol, Danielle

2. Overall survival in patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer treated with a cyclin-dependent kinase 4/6 inhibitor plus fulvestrant: a US Food and Drug Administration pooled analysis. Issue 11 (November 2021)

Authors:
Gao, Jennifer J; Cheng, Joyce; Prowell, Tatiana M; Bloomquist, Erik; Tang, Shenghui; Wedam, Suparna B; Royce, Melanie; Krol, Danielle; Osgood, Christy; Ison, Gwynn; Sridhara, Rajeshwari; Pazdur, Richard; Beaver, Julia A; Amiri-Kordestani, Laleh
Journal:
Lancet oncology
Issue:
Volume 22:Issue 11(2021)
Page Start:
1573
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗